标准for不良术语标准For 系统标签: adverseterminologyvcogcriteria术语events VCOG-CTCAE v1.1 1 Veterinary cooperative oncology group – common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1 PUBLISHDATE: July, 2011 A conse...
Maryland 20892 Common Terminology Criteria for Adverse Events (CTCAE) - Glossary Report 2 of 34 -- A -- accentuation achalasia acrocyanosis acute infusion reaction ADD ADH ADL ADL Adverse Event (AE) aerodigestive tract Alcohol Intolerance Syndrome aliment ALSO CONSIDER ALT altered GI function amenor...
Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAE v3.0) were released in 2003 and have been used widely to report toxicity in publications or presentations describing cancer clinical trials. Here we evaluate whether guidelines for reporting toxicity are followed in publications reporting...
Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE (TM)) Background: Integrating the patient's perspective Jaehde,U.,Ortland,... - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》 被引量...
Acute toxicities were scored using the National Cancer Institute's Common Terminology Criteria for Adverse Events version 3.0, and late toxicities were scored... JK Salama,MD Hasselle,SJ Chmura,... - 《Cancer》 被引量: 297发表: 2012年 A proposed EGFR inhibitor dermatologic adverse event-specific...
Purpose The National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is a library of question items that enables patient reporting of adverse events (AEs) in clinical trials. This study contributes content validity evidence of the...
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Natl Cancer Inst. 2014;106.Basch E, Reeve B, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP...
Teriparatide was selected as the control due to two criteria: (i) its mechanism of action being distinct form bisphosphonates and denosumab, (ii) large number or reports necessary to ensure statistical significance of the results. Monotherapy cohorts for alendronate (n = 7,821), zoledronate ...
(http://.meddramsso).CommonTerminologyCriteriaforAdverseEventsv4.0(CTCAE)PublishDate:May28,2009QuickReferenceTheNCICommonTerminologyCriteriaforAdverseEventsisadescriptiveterminologywhichcanbeutilizedforAdverseEvent(AE)reporting.Agrading(severity)scaleisprovidedforeachAEterm.ComponentsandOrganizationSOCSystemOrganClass,...
adverseevents(AEs)incancerclinicaltrialsinvolvesinvestigatorreportingusingtheNationalCancerInstitute’s(NCI’s)CommonTerminologyCriteriaforAdverseEvents(CTCAE).BecausethisapproachunderdetectssymptomaticAEs,theNCIissuedtwocontractstocreateapatient-reportedoutcome(PRO)measurementsystemasacompaniontotheCTCAE,calledthePRO-CTCAE...